Kanti R. Rai, MD, Jacqueline C. Barrientos, MD | Authors


CLL in the Era of Targeted Therapies

November 09, 2017

Over the past few years, remarkable advances have been achieved in the field of CLL by rationally targeting pathways overexpressed and used by the malignant clone for proliferation and survival. These developments have been achieved by a better understanding of the underlying biology and the disease process.